Crinetics Pharmaceuticals CRNX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's current ratio?
- Crinetics Pharmaceuticals (CRNX) reported current ratio of 18.6× in Q1 2026.
- How has Crinetics Pharmaceuticals's current ratio changed year-over-year?
- Crinetics Pharmaceuticals's current ratio decreased by 17.4% year-over-year, from 22.5× to 18.6×.
- What is the long-term trend for Crinetics Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's current ratio has grown at a -6.1% compound annual growth rate (CAGR), from 16.9× to 12.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.